All data is delayed
Loading...
See More

Litha to acquire Goldex

May 03 2011 17:57
I-Net Bridge
Johannesburg - Litha Healthcare Group [JSE:LHG] said on Tuesday that it had signed an agreement to acquire Goldex Healthcare, a Durban-based pharmaceutical company, in a deal that would result in the company rapidly expanding its pharmaceutical pipeline.

Formerly Myriad Medical Holding, Litha said that the cash deal would see it obtain a 100% share in the company, for a total value of R33m, funded through internally generated cash.

Goldex manufactures and distributes its own pharmaceutical products, and is an exclusive distributor for Unichem Laboratories, an Indian multinational.

By acquiring and integrating the Goldex product range, the Litha Healthcare Group said it would build scale and secure product pipelines for its Litha Pharma Division.

The company's products comprise prescription and over-the-counter medicines.

Goldex Healthcare promotes products including Sinustat and its product line holds 32 active pharmaceutical products that include mainly generics. It said it also had a number of products awaiting registration at the Medicines Control Council.

"Realising the need for continuity, Litha and Goldex Healthcare have agreed to an eight-month handover period until December this year. Thereafter, Litha Group will transfer the Goldex business to our headquarters in Johannesburg. We anticipate that the longer handover period will ensure a smooth transition of the Goldex business into the Litha Group," said Selwyn Kahanovitz, group CEO for the Litha Healthcare Group.

According to Litha, Goldex had experienced considerable growth and success in the generic pharmaceutical sector in southern Africa over the past three years. Part of this growth was due to its strong relationship with Unichem India. 
litha healthcare group

 
 
 

Read Fin24’s Comments Policy

24.com publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
0 comments
Add your comment
Comment 0 characters remaining
 

Company Snapshot

We're talking about:

SMALL BUSINESS

Myths that funding and red tape are the two biggest challenges faced by emerging companies and entrepreneurs, have been debunked by a report.
 

Money Clinic

Money Clinic
Do you have a question about your finances? We'll get an expert opinion.
Click here...

Voting Booth

Sarb’s possible intervention in the markets to stem the rand’s fall is:

Previous results · Suggest a vote

Loading...